Literature DB >> 18038495

Juvéderm: a hyaluronic acid dermal filler.

Gary D Monheit1, Chad L Prather.   

Abstract

Over the past decade, the use of nonsurgical products and devices to correct facial contour defects and signs of skin aging has exploded with new lasers, toxins for muscle relaxation, and dermal fillers revolutionizing aesthetic medicine. Of all the nonsurgical modalities employed during this period, the dermal filler industry has seen the most growth in demand. In 2006, the worldwide market for dermal fillers increased by 19%; and the US market is expected to increase a further 20% to 25%. This is due in large part to new products, particularly the hyaluronic acids such as Juvéderm, which now promise greater longevity, fewer side effects, a more natural appearance, and easier administration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18038495

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  2 in total

1.  Objective 18-month Comparison of the Tolerability of 2 Dermal Fillers Formulated with Tri-Hyal Technology.

Authors:  Patrick Trevidic; Pierre Andre; Laurent Benadiba; Jean-Jacques Deutsch; Olivier Galatoire; Philippe Garcia; Anne Grand-Vincent; Sylvie Boisnic; Catherine Salomon; Ferial Fanian
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-12-09

2.  Long-Lasting Effect after Single Hyaluronate Injection for Unilateral Vocal Fold Paralysis: Does Concentration Matter?

Authors:  Yi-Chieh Lee; Yu-Cheng Pei; Yi-An Lu; Hsiu-Feng Chung; Hsueh-Yu Li; Li-Ang Lee; Tuan-Jen Fang
Journal:  Biomolecules       Date:  2021-10-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.